08 July 2010

Drug Company Payoffs:

Before heading home for a weeklong recess, the House of Representatives passed a bill on July 1 that would crack down on a devious tactic used by some pharmaceutical companies. The tactic, known as “pay for delay,” involves business deals in which the makers of patented brand-name drugs pay generic competitors to delay the introduction of cheaper alternatives.

No comments:

Post a Comment

Please feel free to post a comment!

These are the thoughts and feelings as they happen. The subject matter and verbage may be of a more mature nature, and may be considered sensitive by some. In respect for that, I shall try to remember to give headers (with some space before post) and attempt to just "suggest" sensitive verbage.

Peace, Blessings, I hope this can help some.